Life Whisperer, the fertility arm of AI healthcare company Presagen, has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF. Currently, PGT-A genetic testing requires a portion of a healthy embryo to be removed and sent away for testing. The procedure is invasive, costly, and potentially risky. Presagen CEO, Dr Michelle Perugini said:…
Kindbody today announced Meredith Whitney as its Chief Financial Officer and newest addition to its female-led executive team. Whitney joins Kindbody as a seasoned leader with a long and illustrious career in finance, having shattered the glass ceiling during her time on Wall Street. Whitney has been one of the most visible female analysts on Wall Street, earning recognition from Fortune Magazine as one…
Based on its recent analysis of the global intrauterine device (IUD) market, Frost & Sullivan recognizes OCON Healthcare (OCON) with the 2021 Global Enabling Technology Leadership Award for creating the world’s first and only 3D spherical copper IUD, the Intra Uterine Ball (IUB) Ballerine. The IUD is made from nitinol, a super-elastic alloy that can retain shape and is an ideal transporter of drugs to the…
Evofem Biosciences has announced that two new data sets from its Phase 3 AMPOWER trial evaluating Phexxi (lactic acid, citric acid, potassium bitartrate) will be presented at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting (ACSM). The meeting will be conducted virtually from April 30 – May 2, 2021. “These new data sets provide clinical insights into how women used Phexxi…
Rhia Ventures is on a mission is to create a vibrant U.S. market for sexual, reproductive, and maternal health that produces equitable outcomes for all. The firm makes direct investments in early- and growth-stage companies, provides technical assistance and resources to portfolio companies, and organizes corporate engagement programs to change social norms, practices, and people that influence the market. Yesterday the firm announced…
Women’s health today is under-served from innovation and clinical science standpoints with outdated practices and lack of much-needed attention from key players including investors and insurers. It is imperative to develop the eco-system, shift mindsets and embrace a holistic, women-centered approach. Today’s Fertility Innovation Summit is the second installment of Women’s Health Innovation Summit’s Women’s Health Innovation Series, which runs throughout 2021. Reproductive-health-supporting technologies and research advances…
Tulip, the world’s largest egg donor database and trusted resource for intended parents to find their ideal donor, today announced the closing of a $1.7 Million seed round. Launched in November of 2020, Tulip has quickly amassed donors from 90% of the agencies in the U.S – with nearly 20,000 egg donors within its database. The user-friendly, online search platform helps intended…
Mayne Pharma has announced that the U.S. Food and Drug Administration (FDA) has approved NEXTSTELLIS for the prevention of pregnancy. NEXTSTELLIS is the first and only contraceptive pill containing E4, a naturally occurring estrogen, now produced from a plant source, with a unique mechanism of action that offers potential advantages over other estrogens. “When speaking with patients about their contraceptive options, one…
